Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11870165

Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2002 Mar 1
First author
Cantù MG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2002 Mar 1;20(5):1158-60. doi: 10.1200/JCO.2002.20.5.1158.
    note
    Source null
    related pmid
    11870154
    relationship
    Comment in

Authors and identifiers

  1. name
    Cantù MG
    type
    Author
  2. name
    Buda A
    type
    Author
  3. name
    Parma G
    type
    Author
  4. name
    Rossi R
    type
    Author
  5. name
    Floriani I
    type
    Author
  6. name
    Bonazzi C
    type
    Author
  7. name
    Dell'Anna T
    type
    Author
  8. name
    Torri V
    type
    Author
  9. name
    Colombo N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cantù MG
    type
    Author
  2. name
    Buda A
    type
    Author
  3. name
    Parma G
    type
    Author
  4. name
    Rossi R
    type
    Author
  5. name
    Floriani I
    type
    Author
  6. name
    Bonazzi C
    type
    Author
  7. name
    Dell'Anna T
    type
    Author
  8. name
    Torri V
    type
    Author
  9. name
    Colombo N
    type
    Author
bibliography ids
  1. nci-bib-e667f8acb9e0afa356154335
book metadata
content sha256
7538a1dc312ae71efba80620b718ec5d88b4ebdf0bdf932a634c518075e3b62d
document type
citation
dois
  1. 10.1200/JCO.2002.20.5.1232
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:11870165
immutable id
pubmed:11870165@7538a1dc312ae71efba80620b718ec5d88b4ebdf0bdf932a634c518075e3b62d
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
5
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1232-7
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2002 Mar 1;20(5):1158-60. doi: 10.1200/JCO.2002.20.5.1158.
    note
    Source null
    related pmid
    11870154
    relationship
    Comment in
outcomes validated
false
pmid
11870165
provenance
batch id
d4e82e28940c878dd0a2
provider
NCBI PubMed ESummary
record sha256
d5ae28c06ecccb046479c81218a7593f896f010241c66962ef1e155a7b900860
response sha256
257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
retrieved at
2026-09-09T23:45:44.017762+00:00
publication date
display
2002 Mar 1
precision
day
year
2002
publication types
  1. Clinical Trial
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/11870165/
title
Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens.

Preserved source evidence · Not medical advice